EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Seroprevalence of West Nile Virus in Tampa Bay Florida Patients Admitted to Hospital during 2020–2021 for Respiratory Symptoms

Emma C Underwood iD, Iset M Vera, Dylan Allen, Joshua Alvior, Marci O'Driscoll, Suzane Silbert, Kami Kim iD, Kelli L Barr iD

Viruses · 2024

DOI: 10.3390/v16050719 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Emma C Underwood und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Global Health and Infectious Disease Research, University of South Florida, Tampa, FL 33612, USA. Hauptthemen laut MEDLINE: West Nile virus, West Nile Fever, Antibodies, Viral, Immunoglobulin G. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

West Nile virus (WNV) is an arbovirus spread primarily by Culex mosquitoes, with humans being a dead-end host. WNV was introduced to Florida in 2001, with 467 confirmed cases since. It is estimated that 80 percent of cases are asymptomatic, with mild cases presenting as a non-specific flu-like illness. Currently, detection of WNV in humans occurs primarily in healthcare settings via RT-PCR or CSF IgM when patients present with severe manifestations of disease including fever, meningitis, encephalitis, or acute flaccid paralysis. Given the short window of detectable viremia and requirement for CSF sampling, most WNV infections never receive an official diagnosis. This study utilized enzyme-linked immunosorbent assay (ELISA) to detect WNV IgG antibodies in 250 patient serum and plasma samples collected at Tampa General Hospital during 2020 and 2021. Plaque reduction neutralization tests were used to confirm ELISA results. Out of the 250 patients included in this study, 18.8% of them were IgG positive, consistent with previous WNV exposure. There was no relationship between WNV exposure and age or sex.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

West Nile virusWest Nile FeverAntibodies, ViralImmunoglobulin GHumansFloridaMaleFemaleMiddle AgedSeroepidemiologic StudiesAdultAgedYoung AdultAdolescentAged, 80 and overEnzyme-Linked Immunosorbent AssayHospitalizationImmunoglobulin M

Stichwörter der Autor:innen

COVID-19ELISAFloridaWest Nile virusemerging infectious diseasesseroprevalence

Substanzen

Antibodies, ViralImmunoglobulin GImmunoglobulin M

Autor:innen und Institutionen

  • Center for Global Health and Infectious Disease Research, University of South Florida, Tampa, FL 33612, USA.
  • Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.
  • Tampa General Hospital, Tampa, FL 33606, USA.

ORCID-Profile: Emma C Underwood, Kami Kim, Kelli L Barr

Zitieren

APA

Underwood, E. C., Vera, I. M., Allen, D., Alvior, J., O'Driscoll, M., Silbert, S., Kim, K., & Barr, K. L. (2024). Seroprevalence of West Nile Virus in Tampa Bay Florida Patients Admitted to Hospital during 2020–2021 for Respiratory Symptoms. Viruses. https://doi.org/10.3390/v16050719

Vancouver

Underwood EC, Vera IM, Allen D, Alvior J, O'Driscoll M, Silbert S, et al. Seroprevalence of West Nile Virus in Tampa Bay Florida Patients Admitted to Hospital during 2020–2021 for Respiratory Symptoms. Viruses. 2024. doi:10.3390/v16050719

BibTeX
@article{Underwood2024,
  author = {Underwood, Emma C and Vera, Iset M and Allen, Dylan and Alvior, Joshua and O'Driscoll, Marci and Silbert, Suzane and Kim, Kami and Barr, Kelli L},
  title = {Seroprevalence of West Nile Virus in Tampa Bay Florida Patients Admitted to Hospital during 2020–2021 for Respiratory Symptoms},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16050719}
}
Kostenlos starten →